Literature DB >> 19762744

Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005.

Joanne E Brady1, Lena S Sun, Henry Rosenberg, Guohua Li.   

Abstract

BACKGROUND: Malignant hyperthermia (MH) is a pharmacogenetic syndrome that variably expresses itself on exposure to triggering agents. MH prevalence in the United States is not well documented. In this study, we assessed the prevalence of MH in New York State hospitals.
METHODS: Using New York hospital discharge data for the years 2001 through 2005, we identified all patients with a diagnosis of MH due to anesthesia using International Classification of Diseases, Ninth Revision, Clinical Modification code 995.86. MH prevalence was evaluated by demographic and clinical characteristics.
RESULTS: Of the 12,749,125 discharges from New York hospitals during the study period, 73 patients had a recorded diagnosis of MH due to anesthesia. Nearly three quarters of the MH patients were male and 71% were patients from emergency/urgent admissions. The estimated prevalence rate of MH was 0.96 (95% confidence interval [CI] 0.67-1.24) per 100,000 surgical discharges and 1.08 (95% CI 0.75-1.41) per 100,000 discharges in which there was any indication of exposure to anesthesia. The estimated prevalence of MH for males was 2.5 to 4.5 times the rate for females.
CONCLUSION: The prevalence of MH due to anesthesia in surgical patients treated in New York State hospitals is approximately 1 per 100,000. MH risk in males is significantly higher than in females.

Entities:  

Mesh:

Year:  2009        PMID: 19762744     DOI: 10.1213/ane.0b013e3181ac1548

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  27 in total

Review 1.  [Malignant hyperthermia syndrome in the intensive care unit : Differential diagnosis and acute measures].

Authors:  W Grander
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-06-07       Impact factor: 0.840

2.  Clinical utility gene card for: malignant hyperthermia.

Authors:  Henry Rosenberg; Henrik Rueffert
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

3.  Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.

Authors:  J R Lopez; V Kaura; C P Diggle; P M Hopkins; P D Allen
Journal:  Br J Anaesth       Date:  2018-08-10       Impact factor: 9.166

4.  Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families.

Authors:  Jerry H Kim; Gail P Jarvik; Brian L Browning; Ramakrishnan Rajagopalan; Adam S Gordon; Mark J Rieder; Peggy D Robertson; Deborah A Nickerson; Nickla A Fisher; Philip M Hopkins
Journal:  Anesthesiology       Date:  2013-11       Impact factor: 7.892

Review 5.  Special article: Future directions in malignant hyperthermia research and patient care.

Authors:  Sharon J Hirshey Dirksen; Marilyn Green Larach; Henry Rosenberg; Barbara W Brandom; Jerome Parness; Robert Scott Lang; Meera Gangadharan; Tyler Pezalski
Journal:  Anesth Analg       Date:  2011-06-27       Impact factor: 5.108

6.  Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle.

Authors:  Genaro C Barrientos; Wei Feng; Kim Truong; Klaus I Matthaei; Tianzhong Yang; Paul D Allen; José R Lopez; Isaac N Pessah
Journal:  J Biol Chem       Date:  2011-12-02       Impact factor: 5.157

7.  Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage.

Authors:  Benjamin Yuen; Simona Boncompagni; Wei Feng; Tianzhong Yang; Jose R Lopez; Klaus I Matthaei; Samuel R Goth; Feliciano Protasi; Clara Franzini-Armstrong; Paul D Allen; Isaac N Pessah
Journal:  FASEB J       Date:  2011-11-30       Impact factor: 5.191

Review 8.  [Anesthesia in children and adolescents with congenital heart defects].

Authors:  T Baehner; O Boehm; M Kliemann; I Heinze; J Breuer; A Hoeft; G Baumgarten; P Knuefermann
Journal:  Anaesthesist       Date:  2015-06       Impact factor: 1.041

9.  Round Table on Malignant Hyperthermia in Physically Active Populations: Meeting Proceedings.

Authors:  Yuri Hosokawa; Douglas J Casa; Henry Rosenberg; John F Capacchione; Emmanuel Sagui; Sheila Riazi; Luke N Belval; Patricia A Deuster; John F Jardine; Stavros A Kavouras; Elaine C Lee; Kevin C Miller; Sheila M Muldoon; Francis G O'Connor; Scott R Sailor; Nyamkhishig Sambuughin; Rebecca L Stearns; William M Adams; Robert A Huggins; Lesley W Vandermark
Journal:  J Athl Train       Date:  2017-03-07       Impact factor: 2.860

10.  Malignant Hyperthermia: A Case Study in the Dental Ambulatory Surgery Setting.

Authors:  Bryant W Cornelius; Shelby Olsen Dib; Regina A Dowdy; Christina K Horton; Katherine Frimenko; Shadee Mansour; Farah Abu Sharkh; Marcus T Joy; David L Hall; Hany A Emam; Courtney A Jatana; Kelly S Kennedy
Journal:  Anesth Prog       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.